19 bør behandling med enten lamivudin eller et andet antiviralt lægemiddel overvejes for at genoprette klinisk kontrol af HBV.
In patients who do not maintain a sustained serological response, consideration should be given to retreatment with either lamivudine or an alternative antiviral agent for resumption of clinical control of HBV.